Dario Health Corp. - Understand $drio stock

$DRIO Market Cap: $26.22 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$23.05M

TTM

Gross Margin

35.55%

TTM

Net Earnings

-$48.62M

TTM

Current Assets

$29.53M

Q3 2024

Current Liabilities

$18.85M

Q3 2024

Current Ratio

156.68%

Q3 2024

Total Assets

$110.0M

Q3 2024

Total Liabilities

$51.44M

Q3 2024

Book Value

$58.51M

Q3 2024

Cash

$15.55M

Q3 2024

P/E

-0.5393

Nov 29, 2024 EST

Free Cash Flow

-$39.37M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	$20.35M	$27.66M	$20.51M	$7.576M	$7.560M	$7.394M	$5.170M	$2.803M	$823.0K	$51.00K	$0.00	$0.00	$0.00
YoY Change	-26.41%	34.82%	170.76%	0.21%	2.25%	43.02%	84.45%	240.58%	1513.73%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	$20.35M	$27.66M	$20.51M	$7.576M	$7.560M	$7.394M	$5.170M	$2.803M	$823.0K	$51.00K	$0.00	$0.00	$0.00
Cost Of Revenue	$14.37M	$18.00M	$12.44M	$5.063M	$4.960M	$5.629M	$3.859M	$3.364M	$1.678M	$2.274M	$0.00
Gross Profit	$5.984M	$9.655M	$3.963M	$2.513M	$2.600M	$1.765M	$1.311M	-$830.0K	-$855.0K	-$2.712M	$0.00
Gross Profit Margin	29.4%	34.91%	19.32%	33.17%	34.39%	23.87%	25.36%	-29.61%	-103.89%	-5317.65%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Selling, General & Admin	$41.93M	$46.82M	$63.24M	$27.98M	$16.61M	$15.78M	$12.43M	$8.120M	$4.140M	$4.700M	$7.640M	$2.040M	$160.0K
YoY Change	-10.45%	-25.97%	126.01%	68.45%	5.26%	26.95%	53.08%	96.14%	-11.91%	-38.48%	274.51%	1175.0%
% of Gross Profit	700.62%	484.89%	1595.71%	1113.41%	638.85%	894.05%	948.13%
Research & Development	$20.25M	$19.65M	$17.22M	$4.433M	$3.690M	$3.676M	$3.297M	$2.154M	$2.565M	$3.943M	$4.912M	$1.501M	$80.00K
YoY Change	3.05%	14.11%	288.43%	20.14%	0.38%	11.5%	53.06%	-16.02%	-34.95%	-19.73%	227.19%	1776.58%
% of Gross Profit	338.37%	203.51%	434.49%	176.4%	141.92%	208.27%	251.49%
Depreciation & Amortization	$4.985M	$356.0K	$282.0K	$190.0K	$180.0K	$207.0K	$195.0K	$387.0K	$335.0K	$549.0K	$839.0K	$24.32K	$0.00
YoY Change	1300.28%	26.24%	48.42%	5.56%	-13.04%	6.15%	-49.61%	15.52%	-38.98%	-34.56%	3350.26%
% of Gross Profit	83.31%	3.69%	7.12%	7.56%	6.92%	11.73%	14.87%
Operating Expenses	$62.17M	$66.47M	$80.46M	$32.42M	$20.30M	$19.45M	$15.73M	$10.27M	$6.843M	$8.646M	$13.56M	$1.501M	$230.0K
YoY Change	-6.46%	-17.39%	148.2%	59.68%	4.35%	23.67%	53.15%	50.09%	-20.85%	-36.25%	803.37%	552.72%
Operating Profit	-$56.19M	-$56.81M	-$76.49M	-$29.90M	-$17.70M	-$17.69M	-$14.42M	-$11.10M	-$7.698M	-$11.36M	-$13.56M	-$3.974M
YoY Change	-1.09%	-25.73%	155.81%	68.94%	0.07%	22.67%	29.89%	44.21%	-32.22%	-16.25%	241.23%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Interest Expense	$2.365M	-$107.0K	-$151.0K	$510.0K	$0.00	-$120.0K	-$1.320M	$230.0K	$580.0K	$2.160M	-$370.0K	-$1.710M	$10.00K
YoY Change	-2310.28%	-29.14%	-129.61%		-100.0%	-90.91%	-673.91%	-60.34%	-73.15%	-683.78%	-78.36%	-17200.0%
% of Operating Profit
Other Income/Expense, Net	-$645.0K	-$5.379M	-$235.0K	$458.0K	-$30.00K	-$115.0K	-$1.324M	$214.0K	$556.0K	-$1.519M	-$369.0K	-$1.712M	-$160.0K
YoY Change	-88.01%	2188.94%	-151.31%	-1626.67%	-73.91%	-91.31%	-718.69%	-61.51%	-136.6%	311.65%	-78.45%	970.1%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Pretax Income	-$59.36M	-$62.19M	-$76.73M	-$29.45M	-$17.74M	-$3.801M	-$5.144M	-$3.972M	-$783.0K	$3.598M	$4.340M	$2.988M	-$390.0K
YoY Change	-4.54%	-18.95%	160.58%	65.98%	366.72%	-26.11%	29.51%	407.28%	-121.76%	-17.1%	45.26%	-866.08%
Income Tax	$64.00K	$4.000K	$32.00K							$0.00	$0.00	$0.00	$0.00
% Of Pretax Income										0.0%	0.0%	0.0%
Net Earnings	-$63.51M	-$62.19M	-$76.76M	-$29.45M	-$17.74M	-$17.80M	-$15.74M	-$10.89M	-$7.142M	-$12.88M	-$13.93M	-$5.687M	-$390.0K
YoY Change	2.12%	-18.98%	160.69%	65.98%	-0.35%	13.09%	44.6%	52.44%	-44.54%	-7.57%	144.96%	1358.21%
Net Earnings / Revenue	-312.06%	-224.88%	-374.21%	-388.66%	-234.66%	-240.78%	-304.51%	-388.41%	-867.8%	-25249.02%
Basic Earnings Per Share	$1.93	$2.54	$4.07	$4.01
Diluted Earnings Per Share	-$2.24	$2.54	$4.07	$4.01	-$7.815M	-$15.21M	-$32.79M	-$41.88M	-$79.33M	-$644.0M	-$1.393B	-$569.0M	-$39.00M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Cash & Short-Term Investments	$37.09M	$49.52M	$36.00M	$28.78M	$20.59M	$11.18M	$3.980M	$1.320M	$2.750M	$1.540M	$2.420M	$1.250M	$920.0K
YoY Change	-25.11%	37.56%	25.09%	39.78%	84.17%	180.9%	201.52%	-52.0%	78.57%	-36.36%	93.6%	35.87%
Cash & Equivalents	$36.80M	$49.36M	$35.81M	$28.59M	$20.40M	$11.00M	$3.720M	$1.090M	$2.670M	$1.450M	$2.260M	$1.230M	$910.0K
Short-Term Investments	$292.0K	$165.0K	$192.0K	$190.0K	$190.0K	$180.0K	$260.0K	$230.0K	$80.00K	$80.00K	$150.0K	$20.00K	$10.00K
Other Short-Term Assets		$1.147M	$1.667M	$1.430M	$260.0K			$500.0K	$930.0K	$290.0K	$510.0K	$410.0K	$10.00K
YoY Change		-31.19%	16.57%	450.0%				-46.24%	220.69%	-43.14%	24.39%	4000.0%
Inventory	$5.062M	$7.956M	$6.228M	$2.290M	$1.410M	$1.380M	$1.180M	$890.0K	$600.0K	$230.0K
Prepaid Expenses
Receivables	$3.155M	$6.416M	$1.310M	$120.0K	$670.0K	$170.0K	$280.0K	$230.0K
Other Receivables	$2.024M	$483.0K	$400.0K	$1.500M	$0.00	$590.0K	$610.0K	$0.00
Total Short-Term Assets	$47.33M	$65.52M	$45.61M	$34.13M	$22.94M	$13.31M	$6.050M	$2.940M	$4.290M	$2.060M	$2.930M	$1.670M	$930.0K
YoY Change	-27.77%	43.68%	33.62%	48.78%	72.35%	120.0%	105.78%	-31.47%	108.25%	-29.69%	75.45%	79.57%
Property, Plant & Equipment	$1.866M	$1.994M	$989.0K	$1.070M	$1.410M	$730.0K	$870.0K	$900.0K	$750.0K	$980.0K	$1.140M	$620.0K	$20.00K
YoY Change	-6.42%	101.62%	-7.57%	-24.11%	93.15%	-16.09%	-3.33%	20.0%	-23.47%	-14.04%	83.87%	3000.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$149.0K	$117.0K	$77.00K	$210.0K	$220.0K	$40.00K	$40.00K	$40.00K	$40.00K	$50.00K	$40.00K	$30.00K	$20.00K
YoY Change	27.35%	51.95%	-63.33%	-4.55%	450.0%	0.0%	0.0%	0.0%	-20.0%	25.0%	33.33%	50.0%
Total Long-Term Assets	$49.06M	$53.67M	$55.17M	$1.280M	$1.630M	$780.0K	$910.0K	$930.0K	$790.0K	$1.020M	$1.190M	$650.0K	$50.00K
YoY Change	-8.59%	-2.72%	4209.84%	-21.47%	108.97%	-14.29%	-2.15%	17.72%	-22.55%	-14.29%	83.08%	1200.0%
Total Assets	$96.39M	$119.2M	$100.8M	$35.41M	$24.57M	$14.09M	$6.960M	$3.870M	$5.080M	$3.080M	$4.120M	$2.320M	$980.0K
YoY Change
Accounts Payable	$1.131M	$2.322M	$5.109M	$2.480M	$1.660M	$2.570M	$1.850M	$1.810M	$980.0K	$710.0K	$590.0K	$250.0K	$30.00K
YoY Change	-51.29%	-54.55%	106.01%	49.4%	-35.41%	38.92%	2.21%	84.69%	38.03%	20.34%	136.0%	733.33%
Accrued Expenses	$6.411M	$6.885M	$8.072M	$3.330M	$2.340M			$1.110M	$680.0K	$880.0K	$920.0K	$320.0K	$90.00K
YoY Change	-6.88%	-14.71%	142.4%	42.31%				63.24%	-22.73%	-4.35%	187.5%	255.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.954M	$8.823M
YoY Change	-55.19%
Total Short-Term Liabilities	$12.49M	$19.35M	$14.38M	$7.030M	$5.220M	$5.160M	$3.020M	$2.930M	$1.690M	$1.620M	$1.510M	$570.0K	$120.0K
YoY Change	-35.44%	34.6%	104.5%	34.67%	1.16%	70.86%	3.07%	73.37%	4.32%	7.28%	164.91%	375.0%
Long-Term Debt	$24.59M	$18.11M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$2.360M	$2.760M	$0.00	$0.00	$0.00
YoY Change	35.82%							-100.0%	-14.49%
Other Long-Term Liabilities	$1.161M	$1.737M	$846.0K	$220.0K	$460.0K	$0.00	$0.00	$7.490M	$2.610M	$4.000M	$2.700M	$2.820M	$660.0K
YoY Change	-33.16%	105.32%	284.55%	-52.17%			-100.0%	186.97%	-34.75%	48.15%	-4.26%	327.27%
Total Long-Term Liabilities	$25.75M	$19.84M	$846.0K	$220.0K	$460.0K	$0.00	$0.00	$7.490M	$4.970M	$6.760M	$2.700M	$2.820M	$660.0K
YoY Change	29.79%	2245.39%	284.55%	-52.17%			-100.0%	50.7%	-26.48%	150.37%	-4.26%	327.27%
Total Liabilities	$38.25M	$39.19M	$15.22M	$7.260M	$5.680M	$5.160M	$3.020M	$10.41M	$6.660M	$8.380M	$4.200M	$3.380M	$790.0K
YoY Change	-2.42%	157.47%	109.67%	27.82%	10.08%	70.86%	-70.99%	56.31%	-20.53%	99.52%	24.26%	327.85%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	28.37M	23.64M	16.59M	5.963M
Diluted Shares Outstanding	28.37M	23.64M	16.59M	5.963M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $26.22 Million

About DarioHealth Corp.

DarioHealth Corp. is a digital health company which offers a user-centric multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company is headquartered in New York City, New York and currently employs 249 full-time employees. The company went IPO on 2013-03-08. The firm operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Industry: Surgical & Medical Instruments & Apparatus Peers: ABBOTT LABORATORIES ASENSUS SURGICAL, INC. Co-Diagnostics, Inc. Electromed, Inc. FONAR CORP NeuroPace Inc PAVmed Inc. KORU Medical Systems, Inc.